ReviewCurrent psychiatry reports2024
How to Mitigate Risk in the Treatment of Patients with Borderline Personality Disorder.
Review in Current psychiatry reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewClinicians treating patients with borderline personality disorder (BPD) experience concerns about risk for adverse events that can lead to litigation or complaints to administrative boards. This paper's goal is to outline steps to ensure the safety of both the patient and clinician. RECENT
findingsReview of available data confirms that psychiatry is a subspeciality with relatively low risk for malpractice litigation, but high risk for complaints to administrative agencies. Examination of litigation and complaints suggests that familiar challenges in work with patients with BPD are frequently cited. Risk management considerations have been impacted in recent years by changes in psychiatric training, health care delivery, and regulations about patient information transparency. Concurrently, empirically validated treatments for BPD have been refined and disseminated. Clinicians can address safety concerns by adapting established risk management guidance with an appreciation of key elements of BPD.
Indexed as
Identifiers
39625602What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.